Compare MMD & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MMD | NAGE |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.4M | 239.0M |
| IPO Year | N/A | 2010 |
| Metric | MMD | NAGE |
|---|---|---|
| Price | $14.24 | $2.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 45.0K | ★ 363.0K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 4.88% | N/A |
| EPS Growth | N/A | ★ 81.82 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $129,423,000.00 |
| Revenue This Year | N/A | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ N/A | $33.56 |
| Revenue Growth | N/A | ★ 29.95 |
| 52 Week Low | $14.43 | $2.87 |
| 52 Week High | $15.82 | $10.52 |
| Indicator | MMD | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 18.51 | 41.20 |
| Support Level | N/A | $2.91 |
| Resistance Level | $15.39 | $3.61 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 0.00 | 19.23 |
NYLI MacKay DefinedTerm Muni Opportunities Fund is a diversified closed-end management investment company. The Fund's primary investment objective is to seek current income exempt from regular U.S. Federal income taxes (but which may be includable in taxable income for the purpose of the Federal alternative minimum tax). Total return is a secondary objective. Under normal market conditions, the majority of its managed assets are invested in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.